Hematological diseases
Conditions
Interventions
Trial group 1:LLMs Decision + Healthcare Worker Response (Strategy/Keyword Prompt)
Technical details:
1. LLMs function: provide keywords or strategic prompts (e.g., topic points, key phrases).
2. Syst
Trial group 2:LLMs Decision + Healthcare Worker Response (Refer to Answer Scrolling)
Technical details:
1. LLMs function: Generate complete reference answers (based on the context of the pre-trained m
Sponsors
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Patients with hematologic diseases aged 18-65 years old. 2.Health education is required during the hospital stay. 3.Capable of understanding and signing the informed consent form. 4.Able to cooperate in completing all experimental indicators and scale assessments
Exclusion criteria
Exclusion criteria: 1.Patients with severe cognitive impairment or inability to communicate. 2.Patients who have an aversion to technological devices or the experimental protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of Patient Education Content Understanding; Patient Satisfaction;Communication Efficiency of Medical Staff; | — |
Countries
China
Contacts
Public ContactXie Wenjun
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed